Biotek-snakken — Juli 2021
-
Lånerne har vel ~ 4 mil aktier at gøre godt med! Og deres interesse er at veksle til en gevinst, på vej ned i kurs - og som det står lige nu får Iterum bare tæsk? Men er det den reelle værdi af aktien? Nej, vil jeg påstå, værdien er som hvis/hvis ikke godkendelse! Alt hvad der rør sig under vejs, er manipulation, og i sidste ende egentlig ligegyldig, hvis insisterer at ville være med helt til ende!
-
som "fjolse afd." skriver: If you don't hold there are plenty that will take the Risk /Reward here and your gone . It's hard to hold some times . I would rather hold . It's especially hard when the whole market is down.
$ITRM might lift your whole portfolio (might) . -
Et spændende tip fra Bullish: https://www.proinvestor.com/boards/94657#postdiv95022
-
Biden-angreb på medicinpriser sender danske koncerner ned. https://www.proinvestor.com/investornyt/676916/novo-biden-angreb-pa-medicinpriser-sender-danske-koncerner-ned
-
Fra "fjolse afd." "Sulopenem". Who decided this name? If translated from latin, would be like "upthepenis"? Simply crazy! I can't beleive this is our labelling problem??? No, impossible! but but but... please change the name! Kunne ikke dy mig synes det rammer ret præcist, undskyld!
-
AegirBio stiger 15-20% igen i dag. Aktien er et sjovt sted, lige mellem biotek og etableret virksomhed: Kæmpeordrer vælter ind, men der er ikke kommet et regnskab endnu, som viser fakta. Med den pipeline, knowhow, patenter, som selskabet har, så er der masser af potentiale udover covid-19-testen. Når (hvis) der kommer en FDA-godkendelse, indtjening i milliardklassen, så skal prisen et helt andet sted hen. Årsagen til covid-19-testens succes ligger i selskabets teknologi, som kan vise sig at frem
-
BergenBio - resultater af 2 fase2 studier af BEM i covid19. Der er effekt, men om det er nok til det bliver rullet ud er nok mere tvivlsomt. https://www.bergenbio.com/wp-content/uploads/2021/07/ECCMID-2021-LB-oral-Bemcentinib-12jul2021-.pdf
-
Bullish +35% nu.
-
40% endte det med.
-
Ugekommentar #1 med Helge Larsen. Om tendenser og aktier, som debatteres på ProInvestor.com. Denne uge kommenterer han på Aegirbio, Ennogie, Genmab, North Media, Novo, Quantafuel og SmallCap Danmark. https://www.proinvestor.com/index.php?p=debat_1&postid=95205
-
Fra "fjolse afd.": I hate seeing this! A Stock that I did so much research on, put every penny that I could muster into, and posted DD since December leading others to believe as I believed! I drank the ITRM Koolaid. and Cory just shrugged his shoulders and now he is trapped in the Politics of BIG PHARM! It would be Illegal for him to say anything promising if he knows the news is grim. This is the reason I had to cut my loss. This is round 3 for Suplomin. Will there be round four? Great Q
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind